ড. মম োঃ ফজ঱ু঱ হক

(1)

-19

ড. মম োঃ ফজ঱ু঱ হক

এমফফ঱(RU), ফিএইচফড ইন ম ইক্র ব ক্ ঱জজ (MU, Thailand) সহক্য গী অধ্য িক

প্র ফিফবদ্য ফবভ গ, র জল হী ফবশ্বফবদ্য ঱ Email: [email protected]

Website: http://103.79.117.242/ru_profile/public/teacher/23106423/profile

(2)

ক োভিড-১৯ (C

^OVID

-19) কী?

 - ।

 -

।



SARS-CoV- (Wu et. al., 2020)

 - -

nCoV (Jiang et. al., 2020)

করোনভাইরাস

drfazlul@ru.ac.bd

(3)

?

SARS-CoV-2

( ) (Schoeman, D. and B.C. Fielding, 2019)

 : ( )

, ( ) , ( ) ( )

(Schoeman, D. and B.C. Fielding, 2019)

 ( )

(Li, F. 2016)

করোনভাইরাস

(4)



।



।



।



?

Rodriguez-Morales, et al., 2020

(5)

?

 ।

 ( )

।

 ।

।

(6)

 ,

।

 SARS-CoV-2

। Angiotensin converting enzyme 2 (ACE2)

 ( ) ACE2 SARS-CoV-2

(Zhang et al. 2020 )

(7)

SARS-CoV-2

, ।

 SARS SARS-CoV

SARS-CoV-2 - . %

(Zhou, P. et al. 2020)।

 Pangolin-CoV

- SARS-CoV-2 - . %

(Zhang et al., 2020)

(SARS-C

^O

V-2) ?

(8)

 SARS-CoV-2

।

, ?

 SARS-CoV-2

, , , ,

(BBC)।

 SARS-CoV-2

( )

(Zhang et al., 2020)

 ( ) SARS-CoV-2 ACE2

।

 (Patient Zero) । Patient

Zero ।

।

(9)

- - ?

 - ।

SARS-CoV-2 (CDC)।

 (SARS-CoV-2) -

(Lauer et al., 2020)



।

 , ,

-

।

 ,

।

(10)

- ?

- (WHO and CDC)

 , ।

 , , , ।

 ।

। ।

 ( %) ।



।

(11)

 -19

- ।

 -19

।

 WHO -19

।

 -19

।

,

।

- ?

(12)

?

 -

-

 ,

-19

 ।



।



।

 ,

, ?

(13)

?

 - - -

।

 ।

-

। -

।

(14)

?

 ।



( ) ।

 , ,

।

 , ।

 , , , , ,

।

- ।

 , , ।

।

(15)

, ?



।

 -





।

 - -

SARS-CoV-2

।



।

(16)

COVID-19 ।

(17)

?

 -19

।



।



।

 ।

(18)

। । -

।

( )

। । । , ।

। ।

।

। ।

।

(19)

,

-19

।

- ।

(20)

- ,

।

 / /

, ।



 ,

-

।

(21)

 / /

,

।

 , ,

, ,

 ,

(22)

SARS-CoV-2

 ( )- -

- (BSL-3) । (WHO-Biosafety)

 SARS-CoV-2 -

- ।

 -

। ,

।

 ,

-19

।

(23)

-



।



।

-

CUH2A, , ,

(24)



।



।



।



।

 _, -

SARS-CoV-2

।

(25)

- ?

 , SARS-CoV-2 -

।

 - SARS-CoV-2

-

^।



-

।



( )

মর গীর গ঱ ব ন ক্কর ফভতক্র তু঱ যুক্ত ক ঠি ফদ্ক্ মুক্ে মেষ্ম (নমুন ) সংগ্রহ কর হ

এরির নমুন ঠি ঱ ক্ব ি ি ক্ন হ

(26)

঱য ক্ব নমুন মেক্ক SARS-CoV-2 এর আরএনএ আ঱ দ্ ঑ ফবশুদ্ধ কর হ । এরির আরএনএ মক ফরভ স স ট্র ন্সজরিক্িজ ন মক এনজ ইম ফদ্ক্ ফডএনএ মত রুি ন্তফরত কর হ ।

এরির রুি ন্তফরত ফডএনএ এর স ক্ে

ফডএনএ-ফবজডং এনজ ইম, ফনউফি঑ি ইড, SARS-CoV-2 এর রুি ন্তফরত ফডএনএ এর জনয ফনফদ্সষ্ট প্র ইম র এবং ফ্লক্রক্সণ্ট ড ই ফমফলক্ ফিফসআর মমফলন চ ঱ ক্ন হ ।

ফিফসআর- এর প্রফত চক্র ফডএনএ সংখ্য বৃজদ্ধ

ি এবং এক্দ্র স ক্ে ফ্লক্রক্সণ্ট ড ই যুক্ত হ ।

যফদ্ িরীক্ষ মদ্খ্ য ময ফিফসআর- এর ম ধ্যক্ম ফ্লক্রক্সণ্ট ড ই যুক্ত ফডএনএ সংখ্য বৃজদ্ধ মিক্ ক্ে তক্ব ধ্ক্র মন঑

হক্ব ময ঐ নমুন SARS-CoV-2 ফে঱।

অে স ৎ মর গী মক ফভড-19 এ আর ন্ত।

আর যফদ্ মতমন ন ঘক্ি তক্ব ধ্ক্র ফনক্ত

হক্ব ঐ নমুন SARS-CoV-2 ফে঱ ন । ফচত্র www.chemistryviews.org

(27)



।



।

 -

- ,

N-95 ,

,

/ , ।

 - ।

(28)

?

 ,

WHO - ।

- ।

।

 -

। -

( )

- ।

।

,

(29)

 -

-

।

 ,

,

। -

। ভিত্র www.empirelifemag.com এ কেক কেওয়ো

ভিত্র www. en.wikipedia.org এ কেক কেওয়ো

(30)



।

-

।

 -

। -

।

ভিত্র www.cosmeticsdesign.com এ কেক কেওয়ো

ভিত্র www.gpsworld.com এ কেক কেওয়ো

ভিত্র www.hermanwells.com এ কেক কেওয়ো

(31)

-

।

 , ,

।

 -

।

 -

।

 (WHO) -

।

(32)

-

19 ।

।

,

-19

। -19

[email protected]

(33)

-19

।

-19

-

,

(34)

-

।

, ,

- ।

, -

,

।

- ।

[email protected] [email protected]

(35)

-

।

-

।

-

। ,

(36)

10 -19 ।

10 -19

-19

,

। -19

।

,

।

(37)

5 - ।

5 -

-

5

-

,

(38)

-19

।

-19

।

(39)

/ -19

।

-19

।

-19

, 36.5 37

। ,

,

-19

-

,

।

(40)

।

,

- ,

(41)

।

, ,

,

(42)

।

SARS-CoV-2

WHO

SARS-CoV-2

(43)

।

-

।

(44)

 Wu, Y., Ho, W., Huang, Y., Jin, D.Y., Li, S., Liu, S.L., Liu, X., Qiu, J., Sang, Y., Wang, Q. and

Yuen, K.Y., 2020. SARS-CoV-2 is an appropriate name for the new coronavirus. The Lancet, 395(10228), pp.949-950.

।

, -19

।

(45)

-19

,

।

-19

।

, ,

-19

। WHO

, -

-

(46)

।

,

।

-19

। WHO

(47)

তেযসুত্রোঃ

 Jiang, S., Shi, Z., Shu, Y., Song, J., Gao, G.F., Tan, W. and Guo, D., 2020. A distinct name is needed for the new coronavirus. The Lancet, 395(10228), p.949.

 Schoeman, D. and Fielding, B.C., 2019. Coronavirus envelope protein: current knowledge. Virology journal, 16(1), p.69.

 Li, F., 2016. Structure, function, and evolution of coronavirus spike proteins. Annual review of virology, 3, pp.237-261.

 Zhang, H., Penninger, J.M., Li, Y., Zhong, N. and Slutsky, A.S., 2020. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive care medicine, pp.1- 5.

 Zhou, P., Yang, X.L., Wang, X.G., Hu, B., Zhang, L., Zhang, W., Si, H.R., Zhu, Y., Li, B., Huang, C.L. and Chen, H.D., 2020. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, 579(7798), pp.270-273.

 Zhang, T., Wu, Q. and Zhang, Z., 2020. Probable pangolin origin of SARS-CoV-2 associated with the COVID-19 outbreak. Current Biology.

 Lauer, S.A., Grantz, K.H., Bi, Q., Jones, F.K., Zheng, Q., Meredith, H.R., Azman, A.S., Reich, N.G. and Lessler, J., 2020. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases:

estimation and application. Annals of internal medicine.

 https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html

 https://www.who.int/news-room/q-a-detail/q-a-coronaviruses

 https://www.chemistryviews.org/details/ezine/11232602/COVID-19_Specific_Testing.html

 https://www.who.int/westernpacific/news/multimedia/infographics/covid-19

 https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public/myth-busters

 https://www.who.int/csr/resources/publications/biosafety/Biosafety7.pdf